Image pharmaphorum Editor Views & Analysis The real impact of COVID-19 on emerging markets When COVID-19 began to spread uncontrollably, numbers of confirmed cases initially grew most quickly in developed economies across China, Europe and then the US. Press releases Partner Content DHC Group and Intouch Group Publish Whitepaper on the Effect... Views & Analysis COVID-19 and cancer: can pharma stymie the pandemic’s impact... The COVID-19 pandemic may lead to increased cases of cancer mortality – what can biopharma companies do to help lessen the impact? Partner Content Partner Content The RARE Youth Revolution has begun RARE Revolution Magazine proudly launches dedicated RARE youth online platform Load more results
Views & Analysis The real impact of COVID-19 on emerging markets When COVID-19 began to spread uncontrollably, numbers of confirmed cases initially grew most quickly in developed economies across China, Europe and then the US.
Views & Analysis COVID-19 and cancer: can pharma stymie the pandemic’s impact... The COVID-19 pandemic may lead to increased cases of cancer mortality – what can biopharma companies do to help lessen the impact?
Partner Content Partner Content The RARE Youth Revolution has begun RARE Revolution Magazine proudly launches dedicated RARE youth online platform
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
